MAY 03, 2018 12:25 AM PDT

Developing Drugs to Combat Antibiotic Resistance

WRITTEN BY: Nouran Amin

In accordance with the World Health Organization (WHO), antibiotic-resistant pathogens may soon become a public health crisis. The effectiveness of current antibacterial drugs are dramatically decreasing and the development of new drugs are going on a slow pace. Additionally, the evolution of antibiotic resistance will most likely make new drugs ineffective. With all these issues at hand, researchers hope to improve the effectiveness of existing antibiotics by targeting a combination of certain active agent properties.

Investigators at the Evolutionary Ecology and Genetics research group at Kiel University developed a systematic experimental analysis of the efficacy of a diverse set of antibiotic combinations against the pathogenic bacterium Pseudomonas aeruginosa. Research associate, Dr. Camilo Barbosa in the Evolutionary Ecology and Genetics research group at Kiel University, performed the evolution experiments with 39 combinations of twelve various active compounds. Barbosa revealed the bacterium to diverse drug pairs for up to 10 days, observing the growth of bacteria in culture and the resulting resistance over time.

Through roughly 1,600 evolution experiments, Barbosa was thus able to systemically document the efficacy of drug combinations on bacterial adaptation. Two main factors crucial for combination efficacy were identified. The first was ‘synergistic effects’ between the active ingredients which were found to be important in enhancing the activity leading to an increase in pathogen eradication. The second key factor was collateral sensitivity where an evolved resistance against one antibiotic drug allows the bacterium to have an increased sensitivity or susceptibly to a second drug.

"With the ACE model we describe, for the first time, the specific properties of drug combinations that enhance treatment efficacy. In this way, we want to help make the fight against bacterial infections more targeted and sustainable in future," explains Professor Hinrich Schulenburg, the head of the research group and spokesperson of the Kiel Evolution Center (KEC), “The present study also emphasizes once again that a successful fight against antibiotic resistance can only succeed if the underlying evolutionary principles are considered for treatment design.”

Sources: MedicalXpress, American Society for Microbiology (ASM)

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 21, 2020
Microbiology
A Fast, Cheap Way to See if Two Antibiotics Work Together
SEP 21, 2020
A Fast, Cheap Way to See if Two Antibiotics Work Together
When a person has a bacterial infection, doctors can prescribe antibiotics. Some antibiotics combos can work better than ...
SEP 30, 2020
Cancer
Chemokines Could be the Key in Controlling Glioma Stem Cells
SEP 30, 2020
Chemokines Could be the Key in Controlling Glioma Stem Cells
The transformation of a healthy cell into a cancerous one often comes with a slew of cellular signaling changes.  T ...
OCT 06, 2020
Drug Discovery & Development
New Immunotherapy Drug Effective Against Lung Cancer
OCT 06, 2020
New Immunotherapy Drug Effective Against Lung Cancer
A new study has confirmed that Tecentriq, an immunotherapy drug, improves survival rates among those with newly diagnose ...
OCT 21, 2020
Microbiology
The First Treatment for Ebola is Approved by FDA
OCT 21, 2020
The First Treatment for Ebola is Approved by FDA
Ebola virus can pass from animals to humans, and between people. Rarely, it causes outbreaks but when it does, they can ...
NOV 11, 2020
Cancer
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
NOV 11, 2020
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
Amongst the most common targets of anti-cancer drugs are small regulatory molecules called cyclin-dependent kinases (CDK ...
NOV 17, 2020
Immunology
6 Injections a Year Prevent HIV Infections
NOV 17, 2020
6 Injections a Year Prevent HIV Infections
Last year, around 1.7 million people became infected with HIV, with around half of these being women. Encouraging result ...
Loading Comments...